These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3751420)

  • 1. [Concentration of benzonal in the blood of epileptic patients at different daily doses and with other anticonvulsants].
    Gromov SA; Stabrovskiĭ EM; Fedotenkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(6):855-8. PubMed ID: 3751420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioimmunologic study of the plasma concentrations of folic acid and various antiepileptic preparations during the treatment of epileptic patients].
    Boldarov AI; Maĭzelis MIa; Vaĭntrub MIa; Zabludovskiĭ AL; Gvirtsman LE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):845-8. PubMed ID: 6880514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolism of the anticonvulsant preparation Benzonal in the human body].
    Okudzhava VM; Chankvetadze BG; Rogava MM; Rukhadze MD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(7):94-5. PubMed ID: 3188784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimisation of epilepsy monotherapy (clinico-pharmacological study)].
    Gromov SA; Khorshev SK
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(7):31-5. PubMed ID: 9511212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinico-pharmacological basis for optimizing the treatment of therapy-resistant forms of epilepsy].
    Gromov SA; Smirnov DP; Khorshev SK
    Eksp Klin Farmakol; 1996; 59(4):11-4. PubMed ID: 9026179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-electroencephalographic observations in epileptic patients during long-term treatment with benzonal].
    Bittner-Manicka M; Wasilewski R
    Neurol Neurochir Pol; 1975; 9(6):727-33. PubMed ID: 812001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A story of "Ayurvedic" tablets and misled epileptic patients.
    Gogtay NJ; Dalvi SS; Rane CT; Pawar HS; Narayana RV; Shah PU; Kshirsagar NA
    J Assoc Physicians India; 1999 Nov; 47(11):1116. PubMed ID: 10862327
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic monitoring in the individualized monotherapy with benzonal of epilepsy patients].
    Gusel' VA; Khorshev SK; Smirnov DP
    Farmakol Toksikol; 1991; 54(4):55-6. PubMed ID: 1786830
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The necessary dosis of antiepileptic drugs in epileptic children during their growth period].
    Breuer U; Lempp R
    Nervenarzt; 1968 Jun; 39(6):266-71. PubMed ID: 5712432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of statistical analysis with a computer of the median effective dose and plasma levels of drugs in the treatment of epilepsy].
    Oller L; Lagunas Hernandez MA; Russi Tintore A; Sabater Tobella J; Oller Daurella L
    Arch Neurobiol (Madr); 1977; 40(1):37-46. PubMed ID: 856097
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in drug therapy and in seizure frequency in an institution for epilepsy patients between 1971 and 1986].
    Wohlhüter M; Wolf P; May T
    Rehabilitation (Stuttg); 1994 Nov; 33(4):195-203. PubMed ID: 7800921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of anticonvulsant level determination in the treatment of epilepsies].
    Loiseau P; Brachet-Liermain A; Legroux M; Jogeix M
    Nouv Presse Med; 1977 Mar; 6(10):813-7. PubMed ID: 322087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtherapeutic levels of phenytoin with standard doses in infants: need to review dosage schedule.
    Rane CT; Gogtay NJ; Kadam VS; Powar HS; Dalvi SS; Kshirsagar NA
    Br J Clin Pharmacol; 1999 Sep; 48(3):465-6. PubMed ID: 10576792
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of anticonvulsant levels in epileptics. I. Serum diphenylhydantoin concentrations in a group of medically indigent outpatients.
    Haerer AF; Grace JB
    Acta Neurol Scand; 1969; 45(1):18-31. PubMed ID: 4979531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hexamidine content of the blood plasma and cerebrospinal fluid in patients with epilepsy].
    Gromov SA; Fedotenkova TN; Stabrovskiĭ EM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(6):66-9. PubMed ID: 3188751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.